FeesSafety
Pluang+

Surgery Partners raises consent fee to $5 per $1,000 for bondholders approving note amendments.

Company Fundamentals
18 Nov 2026, 14:30 WIB
GlobeNewsWire
View Source
Neutral
Surgery Partners raises consent fee to $5 per $1,000 for bondholders approving note amendments.

Surgery Partners' subsidiary, Surgery Center Holdings, increased the consent fee from $2.50 to $5.00 per $1,000 principal for holders of its $1.225 billion 7.25% Senior Notes due 2032 who approve proposed amendments to the notes' indenture. The consent solicitation expires on November 20, 2026, and holders who previously consented remain eligible for the increased fee without further action. Payment depends on receiving consents from a majority of noteholders and will be made promptly after the solicitation ends, regardless of whether a related merger is completed. This move aims to encourage noteholders to approve changes tied to a pending acquisition by Bon Secours Mercy Health, Inc.

Surgery Partners' recent consent fee increase is presented here with Pluang's Financials-sector market data as of Nov 18, 2026 18:41 WIB. Among 142 priced US Financials stocks on Pluang, 81 rose and 52 fell today. Notable movers include MARA at USD 6.58 with a 1-day change of +2.49%, BTBT at USD 0.68 with +2.40%, and MUFG at USD 20.95 with +2.34%.

More News

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Major Memphis health system expands Daxor's blood volume testing to new outpatient site with 24-hour results.

Daxor Corporation announced that a major Memphis health system has expanded its Blood Volume Analysis (BVA) program to an additional hospital outpatient site using Daxor’s ezBVA Lab service. This expansion allows the outpatient clinic to receive bloo...

Market News
Bullish
19 minutes ago
Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
1 hour ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
1 hour ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App